Additional OS details for T-DM1

Roche (SIX:ROG; OTCQX:RHHBY) and its Genentech Inc. unit said T-DM1 led to median overall survival (OS) of 30.9 months vs. 25.1 months for Tykerb

Read the full 240 word article

User Sign In